Figure 1
Figure 1. Five-year probabilities of transplantation-related mortality after T cell–replete, ATG-containing, and alemtuzumab-containing transplantations.

Five-year probabilities of transplantation-related mortality after T cell–replete, ATG-containing, and alemtuzumab-containing transplantations.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal